Lilly migraine drug wins European panel thumbs-up
September 21, 2018 at 07:24 AM EDT
A European Medicines Agency panel on Friday recommended the approval of U.S. pharmaceutical group Eli Lilly's migraine treatment, bringing the drug one step closer to being sold in the European Union.
